Purchase Order VA24916P1864
- Not listed
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Therakos, Inc., a foreign-owned, for-profit corporation that specializes in photopheresis medical technology and pharmaceutical products. The contract, valued at $165,330.00, is for the provision of photopheresis kits required for the photopheresis machine used in patient care. The contract does not have a set-aside designation and has an ultimate completion date of May 1, 2016. Therakos,...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 9 (VISN 9), a regional network within the U.S. Department of Veterans Affairs (VA), to Therakos, Inc., a foreign-owned, for-profit corporation. The $185,975.00 contract is for the emergency procurement of Therakos' CELLEX Photopheresis System kits to support immediate patient care. Therakos is a specialized medical technology and pharmaceutical company that provides photopheresis equipment,...
- This firm-fixed price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 9 to Therakos, Inc., a foreign-owned for-profit corporation, for the purchase of 18 photopheresis kits. The potential value of the award is $51,264.00 and the completion date is December 18, 2023. The contract is not associated with any socioeconomic set-aside programs. Therakos is a provider of photopheresis products and services to...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded Therakos, Inc., a foreign-owned for-profit company, a $316,030.86 firm fixed-price purchase order contract to provide photopheresis procedural kits and supplies. The contract, which has no set-aside designation, supports veteran healthcare programs through the delivery of photopheresis system kits, UVADEX medication, and associated supplies to VA medical facilities. This contract award is part of Therakos' larger...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 9 (VISN 9) of the Department of Veterans Affairs (VA) to Therakos, Inc., a foreign-owned, for-profit corporation, for the provision of photopheresis kits and supplies. The contract has a ceiling value of $304,542.00 and a period of performance ending on September 30, 2021. Therakos, Inc. is the prime contractor, and there are no major subcontractors mentioned. The contract supports the VA's healthcare...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order to Therakos, Inc., a foreign-owned for-profit organization, to provide photopheresis kits. The $942,580.00 contract has a performance period ending on October 25, 2018 and was awarded on October 26, 2017. Therakos will deliver the photopheresis system kits, UVADEX medication, and associated supplies to VA medical facilities in Tennessee to support veteran healthcare programs....
- This is a federal contract awarded by the Department of Veterans Affairs (VA) to Therakos, Inc., a foreign-owned, for-profit company specializing in photopheresis medical technology and pharmaceutical products. The contract is for the supply of photopheresis kits needed at the Nashville VA Medical Center for patient care. The contract was awarded on October 24, 2016, with a ceiling value of $944,858.24 and an ultimate completion date of November 12, 2019. The contract is a firm fixed-price...
- This is a firm fixed-price contract awarded by the Veterans Integrated Service Network 9 (VISN 9) of the Department of Veterans Affairs (VA) to Therakos, Inc., a foreign-owned, for-profit corporation specializing in photopheresis medical technology and pharmaceutical products. The contract is for the procurement of CELLEX Photophoresis Procedural Kits, with a ceiling value of $111,708.00 and a completion date of June 27, 2025. This contract is not set aside and is an order under a Blanket...
- The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 awarded a Blanket Purchase Agreement (BPA) to Therakos, Inc., a foreign-owned, for-profit corporation, for the provision of a photopheresis system and associated supplies. The award, valued at $106,524.00, is a firm-fixed price contract with a period of performance through August 5, 2024. Therakos, Inc. is the prime contractor and will be delivering the CELLEX Photopheresis System, UVADEX medication, and related...
- This is a federal contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Therakos, Inc., a foreign-owned, for-profit corporation, to provide Therakos Cellex Photopheresis System procedural kits and light assemblies. The contract, valued at $492,732.00, is a firm fixed-price Purchase Order with economic price adjustment, awarded on November 1, 2018 with a completion date of July 30, 2021. The contract is for the supply of photopheresis system disposables and...
This is a $181,965.00 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Therakos, Inc., a foreign-owned, for-profit corporation specializing in photopheresis medical technology and pharmaceutical products. The contract is for the emergency purchase of Therakos Photopheresis Kits to support immediate patient care. The contract is not set-aside and has an ultimate completion date of February 5, 2016. Therakos, Inc. holds several Indefinite Delivery Vehicle (IDV) contracts with the VA and the National Institutes of Health (NIH) Clinical Center, including a $3.49 million Blanket Purchase Agreement for photopheresis light kits, UVADEX medication, and photopheresis systems, a $750,000 Federal Supply Schedule contract for pharmaceuticals and drugs, and a $163,904 Indefinite Delivery Contract for preventative maintenance on CELLEX photopheresis equipment. These IDV contracts enable federal healthcare facilities to procure Therakos' specialized photopheresis products and services as needed to support patient care and research initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $182.0k | 2/2/16 |